dong ni.jpg

DONG NI, M.D., PH.D

Status

Dr. Dong Ni is currently an Visiting Scholar in the Pennsylvania Cancer and Regenerative Medicine Research Center, a part of the Baruch S. Blumberg Institute in Doylestown, Pennsylvania.

 

background

Dr. Dong Ni holds a Medical Degree in Urology from Medical College of Nankai University, in Tianjing, China. He did clinical practice in the Department of Urology as a Physician in the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.

 

Publications

Selected Original Papers:

1. Ni D, Ma X, Li HZ, Gao Y, Li XT, Zhang Y, Ai Q, Zhang P, Song EL, Huang QB, Fan Y, Zhang X. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma. Clinical cancer research 2014;20(7):1779-90.

2. Ni D, Ma X, Li H, Wang B, Zheng T, Ai Q, Zhang P, Song E, Huang Q, Gao Y, Zhang X. Laparoendoscopic single-site urethrovesical anastomosis training in an economical porcine model. Urologia internationalis. 2014;92(1):89-94.

3. Ni D, Ma X, Li HZ, Gao Y, Li XT, Zhang Y, Ai Q, Huang QB, Duan JY, Zhang X. Factors associated with postoperative renal sinus invasion and perinephric fat invasion in renal cell cancer: treatment planning implications. Oncotarget. 2018;9(11):10091-9.

4. Zhang P, Ma X, Song E, Chen W, Pang H, Ni D, Gao Y, Fan Y, Ding Q, Zhang Y, Zhang X. Tubulin cofactor A functions as a novel positive regulator of ccRCC progression, invasion and metastasis. International journal of cancer. 2013;133(12):2801-11.

5. Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai Q, Ni D, Chen W, Zhang P, Song E, Wang B, Shi T, Zheng T, Zhang X. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Urologic oncology. 2014;32(1):46 e9-17.

6. Gao Y, Li H, Ma X, Fan Y, Ni D, Zhang Y, Huang Q, Liu K, Li X, Wang L, Gu L, Yao Y, Ai Q, Du Q, Song E, Zhang X. KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1. Cancer research. 2017;77(2):330-42.